reviewNature Chemical BiologySep 16, 2019Closed access

Development of targeted protein degradation therapeutics

PPPhilip P. ChamberlainLGLawrence G. Hamann

Bristol-Myers Squibb (Switzerland)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

473
total citations
FWCI
18.80
Percentile
100%
References
77
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Cereblon
  • Computational biology
  • Drug discovery
  • Protein degradation
  • Ubiquitin ligase
  • Drug development
  • Ubiquitin
  • Biology
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.